Redefining trial access
Re:Cognition Health and Cera collaborate to expand access to Alzheimer’s and neurodegenerative clinical trials
Read More
Author: PharmaTimes
EHP Awards triumph
Recognising the achievements of this year’s standout healthcare collaborations
Read More
Book your tickets and join the PM Society for the 40th PM Awards on 20 March 2026
The PM Awards celebrate creativity in pharmaceutical marketing and healthcare communications
Read More
TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform
TQ Therapeutics (TQx) has acquired Juno Therapeutics GmbH, the German subsidiary of Juno...
Read More
Eli Lilly acquires SiteOne Therapeutics to advance treatment for chronic pain
Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the...
Read More- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
